BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PTEN
,
G-protein-coupled receptor binding
,
Diabetes mellitus
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rna caps
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IFIT2
CCL5
IFNL1
CCL2
IFIT1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
NUYTTEN_EZH2_TARGETS_UP
GSE42021_TREG_VS_TCONV_PLN_UP
GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN
GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung epithelial cells treated with an RIG-I agonist or INFa-2b
Explore Curated Studies Results
Literature
Most Relevant Literature
Reconstitution of RNA cap methylation reveals different features of SARS-CoV-2 and SARS-CoV methyltr…
NADcapPro and circNC: methods for accurate profiling of NAD and non-canonical RNA caps in eukaryotes…
5'-cap RNA/SAM mimetic conjugates as bisubstrate inhibitors of viral RNA cap 2'-O-methyltransferases…
Diadenosine Tetraphosphate (Ap4 A) Serves as a 5' RNA Cap in Mammalian Cells.
Structural basis for RNA-cap recognition and methylation by the mpox methyltransferase VP39.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-3…
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema
A Trial to Evaluate the Safety and Efficacy of CLDN6 CAR-T +/- CLDN6 RNA-LPX
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Leukocyte Morphological Parameters as Prognostic Markers in CAP
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ